National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Isavuconazole (Cresemba®) is indicated for the treatment of invasive aspergillosis

Rapid Review

Commenced Completed Outcome
11/04/2016 11/05/2016 Full Pharmacoeconomic Evaluation Recommended at the submitted price.

The HSE has approved reimbursement following confidential price negotiations: April 2018